GSK reported a 15% decline in vaccine sales, offset by a 19% rise in Speciality Medicines revenue in Q3. Operating profit dropped 86% due to a £1.8 billion charge.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
GSK reported a 15% decline in vaccine sales, offset by a 19% rise in Speciality Medicines revenue in Q3. Operating profit dropped 86% due to a £1.8 billion charge.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.